⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NRXP News
NRX Pharmaceuticals, Inc. Common Stock
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in NowRx, Inc. of Class Action Lawsuit And Upcoming Deadlines
accessnewswire.com
NRXP
Bronstein, Gewirtz & Grossman LLC Urges NowRx, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
NRXP
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in NowRx, Inc. of Class Action Lawsuit and Upcoming Deadlines
prnewswire.com
NRXP
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in NowRx, Inc. of Class Action Lawsuit and Upcoming Deadlines
accessnewswire.com
NRXP
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in NowRx, Inc. of Class Action Lawsuit and Upcoming Deadlines
globenewswire.com
NRXP
Bronstein, Gewirtz & Grossman LLC Urges NowRx, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
NRXP
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in NowRx, Inc. of Class Action Lawsuit and Upcoming Deadlines
accessnewswire.com
NRXP
NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions
globenewswire.com
NRXP
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in NowRx, Inc. of Class Action Lawsuit And Upcoming Deadlines
accessnewswire.com
NRXP
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in NowRx, Inc. of Class Action Lawsuit And Upcoming Deadlines
accessnewswire.com
NRXP